NEW YORK (GenomeWeb News) - Curidium Medica said today that it has joined the Personalized Medicine Coalition, a US-based non-profit that aims to advance personalized medicine concepts and products.
 
The PMC is composed of pharmaceutical, biotechnology, diagnostics, and information technology companies.
 
Curidium is a UK-based developer of blood-based diagnostics for disorders of the central nervous system.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.